Stock Analysis · Bulls vs Bears

Repay Holdings Corporation RPAY

🐂 Bulls vs Bears 🐻Report #212 Oct 2026
★ Willem owns this stock · 1.8% of the portfolio
41
moderate risk▼ −11 vs last
🐂 9vs12 🐻
Bears lead
28%
▲ Chance of the biggest tailwind the forecasts miss
85%
▼ Chance of the biggest headwind the forecasts miss
The verdict

The business is not in danger. It is FCF-positive, has no maturity before 2029 except $5M a year of amortisation, and has covenant headroom of more than 2x. But the near-term evidence leans bear: guidance needs standalone revenue growth of about +15–19% in H2 after +5% in H1, from a management team that has missed most of its own targets since 2024. The takeover floor that carried the bull case has gone quiet: there…

The Bulls vs Bears podcast is being made
Two AI hosts debate this report, NotebookLM-style. It appears here automatically within a few hours.

Written by Claude (Anthropic’s AI) from public sources · Willem owns RPAY · AI can make mistakes — numbers in brackets point to the sources · Not financial advice

🐂 Bull arguments 9

  1. 1A $5.25 cash bid exists, 37% above today's priceMedium
  2. 2Embedded in 352 software systems, with no client above 10%Strong
  3. 3About 6x EBITDA and a double-digit FCF yield on equityMedium
  4. 4KUBRA still grows, even in print and mailMedium
  5. 5No maturity wall before 2029, and covenant headroom is wideMedium
  6. 6Business Payments grows 19% normalisedWeak
  7. 7Card-network settlement could widen surcharge and fee rightsWeak
  8. 8Cross-selling between lenders and utilities is optional upsideWeak
  9. 9Elevated consumer delinquencies feed collections volumeWeak

🐻 Bear arguments 12

  1. 1Guidance needs H2 standalone growth of 15–19% after 5%High
  2. 2Net debt is ~5.2x reported EBITDA at a 9.16% floating rateHigh
  3. 3The 2029 converts will cost roughly three times as much to refinanceMedium
  4. 4Management has missed most of its own targets since 2024Medium
  5. 5The board said no twice; insiders sell, none buyMedium
  6. 6Paymentus grows five times faster in the same bill-pay marketMedium
  7. 7Cash leaks before FCF: TRA, capitalised software, partner buyoutsMedium
  8. 8KUBRA dilutes margins and its deal figures don't reconcileMedium
  9. 9Card-network and state fee rules move against B2B and debitMedium
  10. 10A history of overpaying: BillingTree compounded EBITDA at 5%Low
  11. 11Political revenue disappears in 2027Low
  12. 12Sponsor banks can cut off high-risk verticalsLow

Bull arguments show how well they survive the devil’s advocate (strong / medium / weak); bear arguments show the damage they could do after the counter-argument (high / medium / low).

Bull case

🐂 Bull #1A $5.25 cash bid exists, 37% above today's price

  • The point: A named buyer has twice put a cash price on the company, and the share register is primed to push for a sale once the defences lapse in 2027.
  • Evidence:
    • Forager Capital owns 11,106,548 shares (12.4%). It bid $4.80 cash on 2026-04-17, and the board rejected it on 2026-05-04. It then bid $5.25 cash on 2026-06-26, a 91% premium to the $2.75 30-day VWAP before its first approach [18,24].
      • Forager says the $5.25 bid has no financing condition and asked only for confirmatory diligence [18].
      • The board rejected $5.25 unanimously on 2026-07-13 as "significantly undervalues", advised by J.P. Morgan [23].
    • Other activist and board-connected holders:
      • Parthenon holds 9.38% (8.9M shares incl. exchangeable units) and has a board seat (Zach Sadek). Its standstill ends the day after the 2027 annual meeting [16,22].
      • Veradace holds ~8.2% [21].
    • At the 2026-06-10 meeting, each director received 28.5–29.1M "withheld" votes, ~36% of votes cast. Say-on-pay passed only 36.8M to 32.8M [15].
    • The rights plan (12.5% trigger) expires 2027-04-13 [17].
    • Stock $3.82 on 2026-10-12, so $5.25 is +$1.43 or +37% [32].
  • Why it matters: A sale is the only route that pays holders quickly, without waiting for deleveraging. The $5.25 bid sits at ~8.1x the 2026 EBITDA guide midpoint, versus ~6x for the stock today (calc).
  • 😈 Devil's advocate: This bull has weakened since report #1.
    • Forager has filed nothing since 2026-06-29. No 13D/A, statement or new bid has appeared from anyone through 2026-10-12 (EDGAR index) [26]. Its share count is not known after June.
    • Parthenon's 13D/A of 2026-07-15 is ownership-only and carries no demand [22]. Its director must hand his RSU shares to Parthenon, so its interests are aligned with value, but it signed a standstill.
    • A buyer now has to fund $787.5M of debt principal plus the $194.3M TRA before any equity [1]. Stephens framed the stock as trading on "two binary outcomes" (independence after KUBRA, or a sale above the rejected bid) when it downgraded on 2026-05-05 [31]. Five months later, neither outcome has moved.
    • The market prices a sale at well under 50% odds: the stock sits 27% below the bid.
  • Verdict: Medium The bid sets a reference value, but there has been no action for 3.5 months, and the next hard date is the pill expiry on 2027-04-13.

🐂 Bull #2Embedded in 352 software systems, with no client above 10%

  • The point: Revenue repeats monthly because Repay is plugged into the loan, collection and billing software its clients run.
  • Evidence:
    • 352 software integrations at Q2 2026, 54 of them from KUBRA [3].
    • Top 10 clients were ~19% of 2025 gross profit (20% in 2024), with ~7 years' average tenure. No client is above 10% [2].
    • KUBRA claims 10+ years' average tenure at its top clients [12].
    • Pro forma Q2 revenue was +5.6% ($144.6M vs $136.9M) [1].
    • In March 2026 management said no major renewals fall outside guidance [29].
  • Why it matters: Predictable volume is what lets a ~3.7x-levered company carry its debt, and it is what a buyer pays for.
  • 😈 Devil's advocate: Stickiness did not stop the 2024–25 client losses, which pushed FY2025 revenue −1.2% [5]. Consolidation among consumer lenders moves clients to the acquirer's processor, and integrations cannot prevent that. Consumer organic growth of 4% in Q2 says the base is not compounding [3].
  • Verdict: Strong as protection for the base. Weak as a growth argument.

🐂 Bull #3About 6x EBITDA and a double-digit FCF yield on equity

  • The point: The market values Repay like a melting business, although it produces cash every year.
  • Evidence:
    • Market cap $336.9M (88.18M shares at $3.82) [33]. Net debt $703.8M (principal $787.5M less $83.7M cash) [1].
    • EV ~$1.04B, or ~$1.23B including the TRA. That is ~6.0x the 2026 adj EBITDA guide midpoint of $172.25M, or ~7.1x including the TRA (calc) [3].
    • LTM FCF was $67.4M (Q3'25–Q2'26), which is 20% of market cap (calc) [1,3,4,5].
    • The FY2026 guide of ~30% conversion implies ~$52M (calc), or ~15% of market cap [3].
    • Consensus non-GAAP EPS is $0.97 for FY26 and $1.16 for FY27 (5 analysts), so ~3.3x FY27 EPS [32].
    • For comparison, Paymentus trades at 33.9x and Flywire at 31.1x trailing EBITDA (StockAnalysis, GAAP basis) [33].
  • Why it matters: With equity only ~a third of EV, each $50M of debt repaid moves ~15% of market cap from lenders to shareholders.
  • 😈 Devil's advocate: The cheapness is real, but much of it is earned.
    • FCF is stated before the TRA payment ($13.7M in H1'26, booked in financing) and before the $22.5M partner buyout in Q1 [1].
    • Adjusted EPS excludes SBC (4.7–7.1% of revenue a quarter) and $25–26M of quarterly acquisition amortisation [1,28].
    • The ~3.3x P/E rests on adjusted figures. The company lost $11.5M GAAP in Q2 [3].
  • Verdict: Medium Cheap on any measure, but after the TRA and interest, cash to equity is closer to $40–50M a year than the $67M headline.

🐂 Bull #4KUBRA still grows, even in print and mail

  • The point: The fear in report #1 was a shrinking print business. The audited numbers show KUBRA growing across most lines.
  • Evidence:
    • KUBRA 2025 audited revenue was $246.6M, +4.8% [13]:
      • EZ Pay payments $121.0M, +10.1%;
      • print and mail $59.4M, +6.2%;
      • professional services $17.5M, −17%.
    • KUBRA revenue in June 2026 was +5% y/y [3].
    • USPS First-Class volume fell 5.0% in FY2025, but the Forever stamp rose to 82c on 2026-07-12, so pass-through pricing lifts revenue per piece [47].
    • Price ~$372M on ~$49M deal-deck adj EBITDA, or ~7.6x [12].
    • The cost-synergy run-rate was >$4.5M at the end of Q2, with >$8M targeted by YE-26 and $20M+ by 2028. These cost savings are "not tied to waiting for a client to come online" [3,28].
  • Why it matters: A non-discretionary utility and government billing stream growing ~5% is good collateral for deleveraging.
  • 😈 Devil's advocate:
    • Print growth is price, not volume. Interpretation: postage pass-through likely carries little margin.
    • Paymentus grows 29% in the same utility vertical [37]. KUBRA's ~5% is share loss in a growing market.
    • KUBRA's gross margin is 45.9% versus ~75% for legacy Repay [13].
    • Implied KUBRA EBITDA of $27.5–30M for seven months is ~$47–51M annualised, flat on the deal deck's $49M even with synergies [21].
  • Verdict: Medium The asset is steadier than feared, but it will not lift the group's growth rate.

🐂 Bull #5No maturity wall before 2029, and covenant headroom is wide

  • The point (new): The capital structure is expensive but not urgent. Repay has 2.5 years before any refinancing is forced.
  • Evidence:
    • Debt maturities are only $2.5M in the rest of 2026 and $5M in 2027 (0.25% a quarter amortisation). The 2026 converts were repaid on 2026-02-02 [1].
    • The single covenant is total net leverage ≤6.10x, tested quarterly from Q3 2026, with no step-downs and an equity cure. Management puts net leverage at ~3.7x [9,3].
    • Revolver: $100M, undrawn [1].
    • The 10-Q says liquidity suffices "for the next twelve months and the following five years". No going-concern language [1].
    • The TRA current portion is $0 at 2026-06-30, versus $13.7M at YE-25. That was "not found" in report #1 [1].
    • Grant Thornton is auditor, ICFR was effective, and there were no restatements [2,15].
  • Why it matters: Time favours the equity. If the H2 ramp is late, the company has room to wait.
  • 😈 Devil's advocate:
    • The springing maturity (91 days before 2029-07-15, unless liquidity covers the converts plus $15M) puts the real deadline at ~April 2029 [9].
    • The excess-cash-flow sweep takes 50% of excess cash flow at first-lien net leverage ≥2.65x and 25% at 2.15–2.65x [9]. Interpretation: at ~2.2x first-lien (calc: $416M ÷ ~$190M PF EBITDA), a quarter of excess cash is pre-committed to lenders.
    • Covenant EBITDA adds back pro forma synergies, so headroom looks wider than it is on reported EBITDA.
  • Verdict: Medium Strong. This is the main reason the Risk Score is moderate, not elevated.

🐂 Bull #6Business Payments grows 19% normalised

  • The point: The B2B arm is growing fast on a larger supplier network.
  • Evidence:
    • Q2 normalised organic growth +19% [3].
    • Per a partial transcript, ~60% of the growth came from ACH monetisation on TotalPay and ~40% from new clients [51].
    • The supplier network is 731,000, about +66% [3].
    • Management guides to mid-teens B2B growth in H2 (conference summary only) [30].
  • Why it matters: Monetising a bigger network adds high-margin revenue without new client wins.
  • 😈 Devil's advocate: Business Payments is small: $14.5M of segment revenue in Q2 [3]. Visa's Level 2/3 data changes squeeze its margin [27]. It carries the $8–10M political revenue that vanishes in 2027.
  • Verdict: Weak Medium.

🐂 Bull #7Card-network settlement could widen surcharge and fee rights

  • The point (new): The Visa/Mastercard merchant settlement would let merchants surcharge and steer more freely. That could make convenience-fee models easier to defend.
  • Evidence:
    • Preliminary approval 2026-06-09 (Judge Cogan, EDNY). Reported terms: credit interchange −10bp for 5 years, wider surcharging, and the right to decline card categories [43].
    • 978 objections have been filed. NACS will appeal if the settlement is approved [44].
    • The CFPB's 2022 pay-to-pay guidance was formally withdrawn on 2025-05-12 [42].
  • Why it matters: Convenience fees paid by the borrower fund part of Repay's take, and their share is still undisclosed.
  • 😈 Devil's advocate: The same settlement lets merchants refuse commercial cards, which hits Repay's virtual-card AP business (Bear #9). Final approval and its effective dates are unknown. Repay has given no quantification [2].
  • Verdict: Weak The net direction is unclear.

🐂 Bull #8Cross-selling between lenders and utilities is optional upside

  • The point: Repay's lenders could buy KUBRA's billing and messaging, and KUBRA's payment volume could move onto Repay's own settlement engine.
  • Evidence:
    • The revenue-synergy target is $5M+ by 2028 [12].
    • Management deliberately left client migrations out of the synergy plan [28].
    • KUBRA's EZ Pay was $121.0M of 2025 revenue [13].
  • Why it matters: Moving that processing in-house would raise margins on revenue Repay already owns.
  • 😈 Devil's advocate: There are no named cross-sell wins after four months. $5M is ~1% of revenue. Utilities change vendors slowly.
  • Verdict: Weak until the Investor Day sets measurable targets.

🐂 Bull #9Elevated consumer delinquencies feed collections volume

  • The point: Stress among borrowers produces more payments through collection agencies, one of Repay's core verticals.
  • Evidence:
    • NY Fed Q2 2026: flow into 90+ day delinquency was 3.00% for autos and 6.97% for cards, "elevated" [48].
    • Credit-union loans grew +4.9% and personal-loan balances are rising (secondary) [48].
  • Why it matters: Volume grows even when lenders tighten.
  • 😈 Devil's advocate: Stressed borrowers pay less often, and lender losses drive the consolidation that cost Repay clients in 2025. In 2020, Repay still grew (revenue +48%, card volume +42%, largely from acquisitions), so the business is not strongly counter-cyclical either way [41].
  • Verdict: Weak

Bear case

🐻 Bear #1Guidance needs H2 standalone growth of 15–19% after 5%

  • The point (new arithmetic): The 2026 guide only works if the legacy business accelerates sharply in the next two quarters.
  • Evidence:
    • Guidance (reiterated 2026-08-10): revenue $490–500M, and "On an organic basis, REPAY expects approximately 10% to 12% revenue growth" [3].
    • KUBRA's 7-month contribution is guided at $150–154M, which implies standalone revenue of ~$340–346M, matching the pre-KUBRA standalone guide [11].
    • Standalone H1'26 revenue was ~$160.7M ($80.8M + $100.7M − $20.8M KUBRA), up ~5% on ~$153.0M (calc) [1,3,4].
    • To hit $340–346M, H2 standalone revenue must be $179–185M against $156.3M in H2'25, or +15% to +19% (calc).
    • Political media adds ~$5–7M in H2 ($8–10M for the year, ~$3M in H1). Without it, H2 still needs ~+11–15% (calc) [28].
    • Q2 Consumer organic growth was +4% [3].
  • Why it matters: Consensus FY26 revenue of $492.1M sits inside guidance [32]. A shortfall would hit estimates, deleveraging and management's credibility before the Investor Day.
  • 🛡️ Counter-argument:
    • Management says enterprise clients from the implementation backlog "went live" and the ramp builds "pretty substantially as we go into Q3" [28].
    • Q4 is seasonally stronger, and political spend lands in Q3–Q4.
    • The 2025 client losses are now lapped [27].
    • Q4'25 normalised gross profit growth of +9% shows the company can post a strong quarter [5].
  • Severity: High The Q3 print (expected ~2026-11-09 to 11-13; not yet announced) is the test. A ~+8% H2 would leave FY26 revenue ~$14M short (calc).

🐻 Bear #2Net debt is ~5.2x reported EBITDA at a 9.16% floating rate

  • The point: The company is levered for the integration plan, not for today's reported earnings.
  • Evidence:
    • Debt principal $787.5M: a $500M term loan at SOFR+5.50% (9.16% at 6/30) and $287.5M of 2.875% converts. Cash $83.7M [1].
    • Net leverage:
      • management's pro forma figure is 3.7x (4.0x at close), with KUBRA and synergies included [3,11];
      • on reported LTM adj EBITDA of $134.3M it is ~5.2x (calc) [1].
    • TRA liability $194.3M on top [1].
    • Run-rate cash interest is ~$54M a year: ~$45.8M on the term loan plus ~$8.3M on the converts (calc). Q2 interest was $8.0M with only one month of the loan [1].
    • Each +100bp in SOFR costs ~$5M a year (calc).
    • The loan came from a direct lender (Silver Point), not the syndicated market. No public rating was found [49].
  • Why it matters: Interest takes ~30% of adj EBITDA. The FY26 FCF conversion guide fell from 45% to 30% because of it [11].
  • 🛡️ Counter-argument: The covenant sits at 6.10x with no step-downs, and nothing matures before 2029 (Bull #5). On full-year KUBRA EBITDA, ~$190M PF, the ratio is ~3.7x, and the company targets <3x by ~Dec-2027.
  • Severity: High Not a solvency issue, but it caps what equity can earn and what a buyer can pay.

🐻 Bear #3The 2029 converts will cost roughly three times as much to refinance

  • The point (new): The $287.5M converts carry a 2.875% coupon and are deep out of the money (conversion ~$13.02 vs $3.82). They will be refinanced, not converted.
  • Evidence:
    • The converts mature 2029-07-15 [1].
    • The term loan springs to ~2029-04-15 unless liquidity covers the converts plus $15M [9].
    • Today's secured debt costs 9.16%, and the revolver costs SOFR+3.75–4.25% [1].
    • The capped call (strike $13.02, cap $20.42) only helps above $13.02 [1].
  • Why it matters: Replacing 2.875% with ~7.5% debt adds ~$13M of annual interest (calc), ~$0.10 per share after tax (estimate). No forecast reaches FY2029–30.
  • 🛡️ Counter-argument: If leverage falls below 3x by 2027, Repay could use FCF and the revolver to retire part of the converts early, or reprice the whole stack. A buyer would refinance it anyway.
  • Severity: Medium High. The event is near-certain, the timing is distant, and the damage is ~9% of today's EPS consensus.

🐻 Bear #4Management has missed most of its own targets since 2024

  • The point: Guidance from this team has not been a reliable floor.
  • Evidence:
    • FY2024 [8,2]:
      • revenue $313.0M vs a $314–320M guide (miss);
      • gross profit ~$241.4M vs $245–250M (miss);
      • adj EBITDA $140.8M vs $139–142M (met);
      • FCF conversion 75% vs ~65% (beat).
    • 2025 [6,7,5]:
      • FCF conversion was targeted at >60% by Q4, cut to >50%, and delivered at 43%;
      • Q4 normalised GP growth was cut to 6–8% and delivered at +9%;
      • revenue fell 1.2% after "well positioned for positive organic results".
    • 2026 [27,28]:
      • Q1 call: "We expect a ramp as we get into Q2 and really into Q3… Our confidence level on those bookings is high". Q2 Consumer organic came in at +4%, and the ramp is now said to arrive in Q3.
      • The FCF conversion promise of "above 45%" (March) became 30% after KUBRA.
    • Management turnover: the co-founder and President left 2026-02-27, and the CFO, an EVP and the head of Consumer all changed within 12 months [2].
    • The Q2 release's quarterly FCF table shows Q4'25 FCF as $(18.7)M, while its headline table says $13.8M. That is a presentation error, not a restatement [3].
  • Why it matters: The cheap valuation assumes guidance. A team that misses on revenue erodes the multiple further.
  • 🛡️ Counter-argument: Adj EBITDA guidance has generally been met. The 2026 EBITDA guide was raised in April [4]. The ICFR is clean, with no restatement [2].
  • Severity: Medium High.

🐻 Bear #5The board said no twice; insiders sell, none buy

  • The point: The people who control the sale decision have shown no conviction with their own money.
  • Evidence:
    • No open-market purchase by any officer or director in 2026 (Form 4s) [26].
    • General Counsel Dempsey sold 36,112 shares at $3.91–4.00 in September under a 10b5-1 plan adopted 2026-06-16 [25].
    • Grants:
      • CEO Morris received 968,309 shares on 2026-03-11 [26];
      • Q1 grants totalled ~6.1M shares, 6.7% of shares, versus a 3.2% four-year average (Veradace's calculation) [21];
      • the plan pool rose by 2.5M shares, passed 46.8M to 23.6M [15].
    • The pill was adopted the day Forager asked to talk [17]. Both bids were rejected without a counter-number [23,24].
  • Why it matters: The gap between $3.82 and $5.25 depends on a board that has chosen leverage over a sale.
  • 🛡️ Counter-argument:
    • Parthenon's director adds an owner's voice [16].
    • Forager bought 2.5M shares at $2.42–3.05 in March–April, so its bid is opportunistic [26].
    • A board can rationally hold out for more, and the Investor Day is its chance to show a higher value.
  • Severity: Medium High.

🐻 Bear #6Paymentus grows five times faster in the same bill-pay market

  • The point (new evidence): KUBRA and Repay are losing relative share in utility bill pay.
  • Evidence:
    • Paymentus Q2'26: revenue $360.7M (+28.8%), transactions +21.4%, adj EBITDA $48.8M. FY26 guide raised to $1,443–1,458M [37].
    • ACI's Biller segment: +5.5% revenue, with segment EBITDA −12.7% on higher interchange costs [39].
    • KUBRA: ~+5%. Repay Consumer: +4% organic [3,13].
    • Paymentus held 97–98% gross dollar retention through 2019–20 [40].
  • Why it matters: The "end-to-end bill-pay platform" story needs KUBRA to win utility RFPs. The share data says it is not winning faster than the market.
  • 🛡️ Counter-argument: No named utility loss to Paymentus was found, in 2025–26 searches. KUBRA's print and presentment bundle is something Paymentus does not offer in-house.
  • Severity: Medium

🐻 Bear #7Cash leaks before FCF: TRA, capitalised software, partner buyouts

  • The point (new): The FCF line understates what leaves the company.
  • Evidence:
    • TRA payments: $13.7M in H1'26 and $16.3M in H1'25, booked in financing, not FCF [1].
    • Capitalised software: $22.0M in H1'26, 12–17% of revenue according to Forager [1,20].
    • A $22.5M "purchase of intangible assets" in Q1'26 bought out a distribution partner's economics. It adds ~$4.5M to 2026 adj EBITDA [1,27].
    • SBC: 4.7–7.1% of revenue a quarter [1].
  • Why it matters: The equity owner sees ~$40–50M a year, not $67M (calc). Deleveraging from 3.7x to <3x needs ~$130M less debt or ~$35M more EBITDA (calc).
  • 🛡️ Counter-argument: Buying out the partner swapped a recurring commission for a one-off payment, so it is value-accretive at ~5x. Management guides capex below 10% of revenue by 2028 [30].
  • Severity: Medium

🐻 Bear #8KUBRA dilutes margins and its deal figures don't reconcile

  • The point: KUBRA brings lower margins and one large client. Three headline numbers from the deal still do not tie.
  • Evidence:
    • Margins: group gross margin fell from 76.1% to 70.1% in Q2 [1]. KUBRA's 2025 gross margin was 45.9%, and its unadjusted EBITDA ~$37.2M against the $49M "adj" figure in the deck (calc) [13,12].
    • One customer was 11.9% of KUBRA's 2025 revenue (~$29M), with no customer above 10% in 2024 [13].
    • Figures that do not reconcile [1,12,13]:
      • revenue: $239M (deck) vs $246.6M (audited);
      • adj EBITDA: $49M vs ~$37M unadjusted, with ~$12M of add-backs not itemised;
      • price: $372M headline vs $354.1M cash at close.
  • Why it matters: The add-backs and the price gap affect how much the deal really earns on its cost.
  • 🛡️ Counter-argument: Differences between audited and deck figures are common in carve-outs. The closing price is "subject to post-closing adjustments" [1]. KUBRA contributed $2.9M of net income in June [1].
  • Severity: Medium

🐻 Bear #9Card-network and state fee rules move against B2B and debit

  • The point: Rules Repay doesn't control are shifting in several places at once.
  • Evidence:
    • Visa/MC settlement terms let merchants refuse commercial cards, a risk to virtual-card AP [43].
    • Visa's Level 2/3 data changes already pressure B2B margins [27].
    • Louisiana banned debit surcharges by retail businesses from 2026-08-01. Bill pay is not clearly covered [46].
    • The Eighth Circuit Reg II ruling (argued ~May 2026) is pending [45].
    • Processor notices mention a Visa 0.10% fee on virtual cards tagged as embedded payments from ~2026-10-23 (UNCONFIRMED).
  • Why it matters: Pricing power is limited, and the 10-K says flat-rate or convenience-fee contracts may not pass on network cost increases [2].
  • 🛡️ Counter-argument: The federal posture is loose (CFPB guidance withdrawn [42]), and Repay has worked inside this rulebook for 20 years. Some changes (lower debit interchange) could cut its costs.
  • Severity: Medium Low.

🐻 Bear #10A history of overpaying: BillingTree compounded EBITDA at 5%

  • The point: Past acquisitions have earned less than they cost, and KUBRA was bought by the same team.
  • Evidence:
    • BillingTree was bought at ~$503M EV, ~18.6x 2021E EBITDA. Repay's group EBITDA grew at only a 5% CAGR from 2021 to 2025, by Forager's figures [20].
    • Goodwill impairments: $103.8M in Q2'25 and $138.9M in Q4'25 [5].
    • KUBRA added $177.6M of goodwill and $237M of intangibles [1].
  • Why it matters: Another impairment would hurt credibility and confirm the "déjà vu" thesis.
  • 🛡️ Counter-argument: KUBRA was bought at ~7.6x, not 18.6x. The impairments were tied to market multiples and discount rates [2].
  • Severity: Low Medium.

🐻 Bear #11Political revenue disappears in 2027

  • The point: The $8–10M of 2026 political media revenue does not recur in 2027.
  • Evidence: Guided at $8–10M for 2026, ~2 points of Q2 organic growth [3,28].
  • Why it matters: 2027 organic growth starts ~2.5 points behind (calc: ~$9M ÷ ~$350M standalone).
  • 🛡️ Counter-argument: It is known and disclosed. Interpretation: FY27 consensus (+27% revenue) should already include it, but this could not be confirmed.
  • Severity: Low

🐻 Bear #12Sponsor banks can cut off high-risk verticals

  • The point: Card-network access runs through sponsor banks with "substantial discretion" [2].
  • Evidence: The 10-K risk factor [2]. Bank enforcement against payment-processor oversight continues, e.g. an OCC consent order against Community Federal Savings Bank in April 2026 (secondary).
  • Why it matters: Debt collection and subprime lending are the first verticals a bank drops.
  • 🛡️ Counter-argument: Repay uses several sponsor banks and runs its own settlement. No disruption has been disclosed.
  • Severity: Low

Tailwinds NOT in the forecasts

Consensus (5 analysts): FY26 revenue $492.1M, non-GAAP EPS $0.97. FY27 revenue $626.9M, EPS $1.16. FY28 consensus was not found [32]. EPS arithmetic uses ~95M shares (89.9M Class A + 5.3M exchangeable units, estimate) and a 25% tax rate (estimate).

  • Sale of the company at ≥$5.00 per share — 28% chance within 36 months

    • Impact on revenue: not applicable (the equity is bought out).
    • Impact on EPS: not applicable. Value per share: +$1.18 to +$1.43 (+31% to +37%) vs $3.82.
    • How we got the number (estimate): $5.00–5.25 offer − $3.82 price.
    • Expected value: 0.28 × ~$1.30 ≈ +$0.36 per share of price (not EPS; the largest tailwind by far).
    • What it is: a take-private by Forager, private equity or a strategic buyer.
    • Why it's not priced in: the stock sits 27% below the last bid, and consensus models a standalone company [32].
    • Trigger to watch: a new 13D/A, the pill expiry on 2027-04-13, a 2027 proxy contest, and the Investor Day tone.
    • Why this probability: down from 33% in report #1. There have been no filings for 3.5 months and the board has not engaged, but a quarter of the register is still activist and Q3 disappointment would raise the pressure.

  • Term-loan repricing once leverage falls below 3x — 35% chance by end-2027

    • Impact on revenue: none.
    • Impact on EPS: +$0.06 (+5% vs FY27 consensus $1.16; full effect lands in FY28).
    • How we got the number (estimate): 150bp lower spread × $500M = $7.5M × 0.75 ÷ 95M ≈ +$0.06.
    • Expected value: 0.35 × $0.06 ≈ +$0.021.
    • What it is: refinancing the Silver Point loan at SOFR+4.00% or less. The repricing premium is only 1% [9].
    • Why it's not priced in: consensus carries the current debt cost.
    • Trigger to watch: net leverage ≤3.3x at Q4 2026 and a first-lien ratio below 2.15x.
    • Why this probability: a direct-lender loan at S+550 is an obvious target once leverage drops, but that needs the H2 ramp that Bear #1 doubts.

  • KUBRA cost synergies ~$10M above the $20M target — 25% chance by 2028

    • Impact on revenue: none (cost).
    • Impact on EPS: +$0.08 (~+7% vs FY27 consensus as the reference; FY28 consensus not found).
    • How we got the number (estimate): $10M × 0.75 ÷ 95M ≈ +$0.08.
    • Expected value: 0.25 × $0.08 = +$0.020.
    • What it is: for example, moving KUBRA's EZ Pay processing onto Repay's own settlement engine, which the plan deliberately excludes [28].
    • Why it's not priced in: the plan stops at $20M+, and the move is outside it.
    • Trigger to watch: the Investor Day target, and run-rate synergies above $8M at Q4.
    • Why this probability: run-rate went from $0 to $4.5M in one month, but management's broader delivery record argues against a big overshoot.

  • Buyback restart with the $23.0M left — 12% chance within 24 months

    • Impact on revenue: none.
    • Impact on EPS: about +$0.06 (+5% vs FY27).
    • How we got the number (estimate): $23M ÷ $3.82 = 6.0M shares (−6.3%) → +$0.07, less lost interest of $23M × 9.16% × 0.75 ÷ 95M = −$0.017.
    • Expected value: 0.12 × $0.06 ≈ +$0.007.
    • What it is: repurchases resume. None were made in H1'26 [1].
    • Why it's not priced in: management's stated priorities are organic growth, then M&A, then deleveraging [27].
    • Trigger to watch: buyback language at the Investor Day.
    • Why this probability: the cash sweep and the <3x promise make buybacks unlikely before 2027.

  • Wider surcharge rights under the Visa/MC settlement — 45% chance of final approval by mid-2027

    • Impact on revenue / EPS: not quantifiable. Convenience-fee revenue is undisclosed and the effective dates are not found.
    • Expected value: not quantifiable.
    • What it is / trigger: the fairness hearing (date unverified; one commentary site says 2026-11-16) and any 2nd Circuit appeal [44].
    • Why this probability: 978 objections and a promised appeal make approval by mid-2027 slightly less likely than not.

Headwinds NOT in the forecasts

  • The 2029 converts are refinanced at roughly three times the coupon — 85% chance by 2029-04

    • Impact on revenue: none.
    • Impact on EPS: −$0.10 a year from FY2030 (−9% vs FY27 consensus as the reference; no FY29–30 consensus exists).
    • How we got the number (estimate): (7.5% − 2.875%) × $287.5M = $13.3M × 0.75 ÷ 95M ≈ −$0.105.
    • Expected value: 0.85 × −$0.105 ≈ −$0.089.
    • What it is: cheap 2021-vintage convertible debt replaced with market-rate debt.
    • Why it's not priced in: no published forecast reaches 2029–30.
    • Trigger to watch: leverage path, any convert repurchases below par, and refinancing talk at the Investor Day.
    • Why this probability: the conversion price is 3.4x the share price, so conversion is effectively off the table. Only a sale or large early paydown avoids it.

  • The H2 organic ramp falls short (H2 standalone ~+8% instead of +15–19%) — 55% chance by the Q4 2026 report (~Mar 2027)

    • Impact on revenue: −$14M in FY26 (−2.9% vs $492.1M), and ~−$28M in FY27 (−4.5% vs $626.9M).
    • Impact on EPS: FY27 −$0.14 (−12% vs $1.16).
    • How we got the number (estimate): $156.3M × (1.17 − 1.08) ≈ $14M per half → $28M a year × 65% incremental margin × 0.75 ÷ 95M ≈ −$0.14.
    • Expected value: 0.55 × −$0.14 ≈ −$0.079.
    • What it is: the "double-digit" promise slips again, as the Q2 ramp did.
    • Why it's not priced in: consensus FY26 ($492.1M) sits inside guidance [32].
    • Trigger to watch: Q3 Consumer organic growth below ~10%, or a guide trimmed to the low end.
    • Why this probability: the needed step from +5% to +15–19% in one quarter, plus the 2024–26 record, makes a miss slightly more likely than not. Named go-lives keep it from being higher.

  • Loss of KUBRA's 11.9% customer — 10% chance within 36 months

    • Impact on revenue: −$29M (−4.7% vs FY27 consensus).
    • Impact on EPS: −$0.11 (−9% vs FY27).
    • How we got the number (estimate): 11.9% × $246.6M = $29.3M × 45.9% gross margin × 0.75 ÷ 95M ≈ −$0.11.
    • Expected value: 0.10 × −$0.11 = −$0.011.
    • What it is: a top utility re-tenders after the change of ownership.
    • Why it's not priced in: management flags no unusual renewals [29].
    • Trigger to watch: KUBRA growth turning negative, or client-loss language.
    • Why this probability: utility tenures run 10+ years, but the customer's identity and renewal date are undisclosed.

  • SOFR averages 100bp higher in FY27 — 20% chance

    • Impact on revenue: a small offset from float income (H1 interest on settlements was only $2.7M) [1].
    • Impact on EPS: −$0.04 (−3% vs FY27).
    • How we got the number (estimate): $500M × 1% × 0.75 ÷ 95M ≈ −$0.04.
    • Expected value: 0.20 × −$0.04 = −$0.008.
    • Why it's not priced in / trigger: consensus assumes the current curve. Watch Fed decisions and the 1-month term SOFR print.
    • Why this probability: no hedging is disclosed and rates are volatile, but a full +100bp is a tail outcome.

  • Commercial-card refusal and new Visa B2B fees hit virtual-card AP — 30% chance within 24 months

    • Impact on revenue / EPS: not quantifiable. Repay does not split virtual-card revenue from Business Payments ($14.5M in Q2).
    • Expected value: not quantifiable.
    • What it is / trigger: the settlement's honor-all-cards change and the reported embedded-payments fee (UNCONFIRMED). Watch B2B margin commentary in Q3.
    • Why this probability: the rules are moving in that direction, but final approval and Visa's implementation are both uncertain.

Investment Risk Score: 41/100 (moderate)

# Factor Weight Measured value Score Why
1 Liquidity & funding runway 15% LTM FCF +$67.4M; cash $83.7M + $100M undrawn revolver; next maturity $5M/yr until ~Apr-2029; TRA current portion $0 35 FCF-positive with no near-term maturities, but the debt is not "modest" and the TRA takes ~$14M a year
2 Leverage 10% Net debt $703.8M; ~3.7x PF (mgmt), ~5.2x reported LTM adj EBITDA; + $194M TRA; 9.16% floating 70 In the 3–5x band on any basis, with expensive floating debt
3 Dilution (last 12 months + overhang) 10% Class A 86.05M → 89.86M (+4.4%), +1.7% excl. unvested; Q1 grants 6.7% of shares; converts out of the money; buyback paused 45 Inside +3–10% on the headline count; equity grants double the historical rate
4 Profitability 10% LTM FCF margin ~20% ($67.4M ÷ $337.8M); FY26 guide implies ~10%; GAAP net loss Q2 −$11.5M 35 Positive FCF, but the guided 2026 margin sits in the 5–15% band and GAAP earnings are negative
5 Revenue quality & concentration 10% Recurring monthly payments; top 10 ~19% of GP; no client >10%; KUBRA 11.9% client ≈ 6% of PF revenue 25 Recurring and diversified; contracts are evergreen, not committed
6 Execution & track record 10% FY24 revenue/GP missed; 2025 FCF target cut twice and missed; Q2-26 ramp slipped to Q3; H2 needs +15–19%; 4 senior exits in 12 months 62 Frequent misses on the lines investors watch, but no material weakness or restatement
7 Competitive position & disruption 10% Consumer +4% organic, KUBRA +5% vs Paymentus +28.8%; 352 integrations 55 A defensible niche, but losing relative share in bill pay
8 Cyclicality & commodity/macro sensitivity 10% Loan and utility payments are non-discretionary; 2020 revenue +48% (mostly M&A); lender consolidation; political swing 30 Mild; the risk is client consolidation, not demand
9 Regulatory, legal & geopolitical 5% Convenience-fee rules, Visa/MC settlement, Reg II ruling pending, sponsor-bank discretion; no material litigation; no geopolitical exposure 42 Material but contained, and federal pressure is low
10 Valuation & expectations 10% ~6.0x EV/EBITDA (7.1x incl. TRA), ~3.3x FY27 consensus EPS, 27% below a rejected bid; short interest 4.5% of float 18 Cheap against history, peers and the bid; low expectations

Overall: weighted average = 0.15×35 + 0.10×(70+45+35+25+62+55+30+18) + 0.05×42 = 5.25 + 34.0 + 2.1 = 41.35 → 41.

Change vs last: −11 versus 52 on the old 6-area method. Most of the drop is the method:

  • the new scale rewards positive FCF (factor 1), a low valuation (factor 10) and low concentration (factor 5);
  • the old method put 25% on "business & competition".

The facts moved little. Execution got slightly worse (the H2 arithmetic). Liquidity got slightly better (TRA current portion $0, $5M a year amortisation confirmed).

Ranking check: RPAY (41) sits level with VIST (41) and just below VLN (45). It is safer than REAX (50), because it is FCF-positive and not housing-cyclical despite higher leverage. It is riskier than CRDO (37), which has net cash.

Conclusion

  • What you are really betting on: a sticky, cash-producing but slow-growing payments niche, levered at ~3.7x. Value comes from three routes:
    1. the H2 ramp proving real, so leverage falls below 3x and the multiple re-rates;
    2. a sale near $5 once the pill lapses in April 2027;
    3. both. Nothing else in the story moves the stock much.
  • The 2–3 things that will decide the outcome:
    1. Whether Q3 and Q4 2026 standalone revenue grows at mid-teens, as guidance needs.
    2. Whether the board or its shareholders reopen a sale after the 2026-12-07 Investor Day and before or at the 2027 annual meeting.
    3. Whether free cash after the TRA and interest cuts net debt by ~$130M by end-2027.
  • Signposts:
    • Bull case confirmed by:
      • Q3 Consumer organic ≥10% with the FY guide held;
      • an Investor Day synergy target above $20M plus a repricing or convert plan;
      • net leverage ≤3.3x at Q4 2026;
      • a new 13D/A or a formal strategic review.
    • Bull case broken by:
      • Q3 Consumer organic below ~8% or a revenue guide cut;
      • no sale engagement and the pill renewed in April 2027;
      • KUBRA growth turning negative or its 11.9% client lost;
      • H2 FCF conversion below 30%, or a covenant EBITDA "add-back" expansion.
  • New since the last report:
    • The H2 guide needs +15–19% standalone growth after +5% in H1, a much steeper ramp than "double digits" suggests.
    • The bid has gone quiet: no Forager filing since 2026-06-29, and no insider bought in 2026.
    • The debt is confirmed as patient but costly: $5M a year amortisation, a single 6.10x covenant, a 25–50% excess-cash sweep, a springing maturity ~April 2029, and 2.875% converts that will reprice to market.

Open questions & data gaps

  • Q3 2026 date has not been announced. The pattern points to a notice in late October and a call around 2026-11-09 to 11-13. High importance.
  • Consensus adj EBITDA and FY28 figures were not found. Without them, the size of every tailwind and headwind is set against FY27 EPS only. Medium importance.
  • KUBRA reconciliation: the $239M vs $246.6M revenue, the ~$12M of EBITDA add-backs and the $372M vs $354.1M price are still unexplained. The purchase agreement and the pro forma exhibit (8-K/A Ex. 99.3) were not read. Medium importance.
  • Covenant EBITDA and the ECF sweep mechanics were not computed, so actual covenant headroom is unknown, only the 6.10x level. Medium importance.
  • Convenience-fee share of revenue, card/ACH mix and virtual-card revenue are still undisclosed. This is the main regulatory sensitivity. Hope for it at the Investor Day.
  • Earnings-call quotes come from third-party transcription pages. Motley Fool says its page is partly LLM-produced, and the allmind.ai page is partial and garbled. They have not been verified against audio.
  • Charles Nabhan, head of IR since 2026-09-01, has the same name as the Stephens analyst who downgraded on 2026-05-05. Likely the same person, but UNCONFIRMED.
  • Forager's current holding and intentions are unknown after June.
  • The Visa embedded-payments fee (~2026-10-23) is UNCONFIRMED, from processor notices only.
Sources
  1. Repay Holdings Form 10-Q Q2 2026 — SEC EDGAR — 2026-08-10 — https://www.sec.gov/Archives/edgar/data/1720592/000119312526342440/rpay-20260630.htm
  2. Repay Holdings Form 10-K FY2025 — SEC EDGAR — 2026-03-09 — https://www.sec.gov/Archives/edgar/data/1720592/000119312526098518/rpay-20251231.htm
  3. REPAY Reports Second Quarter 2026 Financial Results (8-K Ex. 99.1) and Q2 deck (Ex. 99.2) — SEC EDGAR — 2026-08-10 — https://www.sec.gov/Archives/edgar/data/1720592/000119312526342425/rpay-ex99_1.htm
  4. REPAY Q1 2026 results (8-K Ex. 99.1) — SEC EDGAR — 2026-05-04 — https://www.sec.gov/Archives/edgar/data/1720592/000119312526204004/rpay-ex99_1.htm
  5. REPAY Q4 and FY2025 results (8-K Ex. 99.1) — SEC EDGAR — 2026-03-09 — https://www.sec.gov/Archives/edgar/data/1720592/000119312526098510/rpay-ex99_1.htm
  6. REPAY Q1 2025 results and outlook (8-K Ex. 99.1) — SEC EDGAR — 2025-05-12 — https://www.sec.gov/Archives/edgar/data/1720592/000095017025069180/rpay-ex99_1.htm
  7. REPAY Q3 2025 results (8-K Ex. 99.1) — SEC EDGAR — 2025-11-10 — https://www.sec.gov/Archives/edgar/data/1720592/000119312525274223/rpay-ex99_1.htm
  8. REPAY Q3 2024 results and FY2024 outlook (8-K Ex. 99.1) — SEC EDGAR — 2024-11-12 — https://www.sec.gov/Archives/edgar/data/1720592/000095017024125356/rpay-ex99_1.htm
  9. Credit Agreement dated 2026-06-01 (8-K Ex. 10.1) — SEC EDGAR — 2026-06-01 — https://www.sec.gov/Archives/edgar/data/1720592/000119312526251442/rpay-ex10_1.htm
  10. Form 8-K: First Amendment to Credit Agreement — SEC EDGAR — 2026-06-15 — https://www.sec.gov/Archives/edgar/data/1720592/000172059226000004/rpay-20260612.htm
  11. REPAY Completes Acquisition of KUBRA, updated 2026 outlook (8-K Ex. 99.1/99.2) — SEC EDGAR — 2026-06-01 — https://www.sec.gov/Archives/edgar/data/1720592/000119312526251442/rpay-ex99_1.htm
  12. REPAY Announces Agreement to Acquire KUBRA, press release and deck (8-K Ex. 99.1/99.2) — SEC EDGAR — 2026-03-30 — https://www.sec.gov/Archives/edgar/data/1720592/000119312526133296/rpay-ex99_1.htm
  13. KUBRA audited financial statements FY2025/FY2024 (8-K/A Ex. 99.1) — SEC EDGAR — 2026-08-17 — https://www.sec.gov/Archives/edgar/data/1720592/000119312526354037/rpay-ex99_1.htm
  14. Repay Form 10-Q Q2 2025 (cover page share count) — SEC EDGAR — 2025-08-11 — https://www.sec.gov/Archives/edgar/data/1720592/000172059225000011/rpay-20250630.htm
  15. Form 8-K: 2026 annual meeting voting results — SEC EDGAR — 2026-06-12 — https://www.sec.gov/Archives/edgar/data/1720592/000172059226000002/rpay-20260610.htm
  16. Form 8-K: Cooperation agreement with Parthenon, appointment of Zach Sadek — SEC EDGAR — 2026-07-14 — https://www.sec.gov/Archives/edgar/data/1720592/000119312526303158/rpay-20260713.htm
  17. Form 8-K: Stockholder Rights Agreement — SEC EDGAR — 2026-04-14 — https://www.sec.gov/Archives/edgar/data/1720592/000119312526153953/d893808d8k.htm
  18. Forager Capital Schedule 13D/A and $5.25 proposal letter (Ex. 99.6) — SEC EDGAR — 2026-06-29 — https://www.sec.gov/Archives/edgar/data/1720592/000165495426006261/forager_ex996.htm
  19. Forager Capital letter to stockholders (Ex. 99.1) — SEC EDGAR — 2026-05-18 — https://www.sec.gov/Archives/edgar/data/1720592/000165495426005086/fcm_ex991.htm
  20. Forager Capital letter to stockholders (Ex. 99.4; BillingTree history) — SEC EDGAR — 2026-05-27 — https://www.sec.gov/Archives/edgar/data/1720592/000165495426005393/fcm_ex994.htm
  21. Veradace Partners Schedule 13D/A and open letter (Ex. 99.1) — SEC EDGAR — 2026-06-04 — https://www.sec.gov/Archives/edgar/data/1720592/000092189526001555/ex991to13da214830002_060426.htm
  22. Beckham Aggregator / Parthenon Schedule 13D/A No. 1 — SEC EDGAR — 2026-07-15 — https://www.sec.gov/Archives/edgar/data/1720592/000121390026078374/primary_doc.xml
  23. REPAY Rejects Revised Unsolicited Proposal from Forager Capital — Business Wire (via Webull) — 2026-07-13 — https://www.webull.com/news/15222157793567744
  24. Repay Rejects Unsolicited Proposal from Forager Capital — Business Wire (via Barchart) — 2026-05-04 — https://www.barchart.com/story/news/1692631/repay-rejects-unsolicited-proposal-from-forager-capital
  25. Form 4, Tyler B. Dempsey (10b5-1 sales) — SEC EDGAR — 2026-09-21 — https://www.sec.gov/Archives/edgar/data/1720592/000119312526396945/ownership.xml
  26. Repay Holdings EDGAR submissions index (all 2026 Forms 4, 13D/A, 8-K) — SEC — accessed 2026-10-12 — https://data.sec.gov/submissions/CIK0001720592.json
  27. Repay Q1 2026 earnings call transcript (partly LLM-produced per publisher) — The Motley Fool — 2026-05-04 — https://www.fool.com/earnings/call-transcripts/2026/05/04/repay-rpay-q1-2026-earnings-call-transcript/
  28. Repay Q2 2026 earnings call transcript — The Motley Fool — call 2026-08-10, published 2026-08-17 — https://www.fool.com/earnings/call-transcripts/2026/08/17/repay-holdings-rpay-q2-2026-earnings-call-transcript/
  29. Earnings call transcript: Repay Holdings Q4 2025 — Investing.com — 2026-03-09 — https://www.investing.com/news/transcripts/earnings-call-transcript-repay-holdings-beats-q4-2025-forecasts-stock-rises-93CH-4578048
  30. Repay at Canaccord Genuity 46th Annual Growth Conference (AI summary) — Quartr — 2026-08-12 — https://quartr.com/events/repay-holdings-corporation-rpay-canaccord-genuity-s-46th-annual-growth-conference_oq2AwIK0
  31. UBS Raises its Price Target on Repay (incl. Stephens "two binary outcomes") — Yahoo Finance / Insider Monkey — 2026-06-07 — https://finance.yahoo.com/markets/stocks/articles/ubs-raises-price-target-repay-050742302.html
  32. RPAY forecast (consensus, 5 analysts) — StockAnalysis — 2026-10-12 — https://stockanalysis.com/stocks/rpay/forecast/
  33. RPAY statistics, and peers PAY/FLYW/GPN/FOUR — StockAnalysis — 2026-10-12 — https://stockanalysis.com/stocks/rpay/statistics/
  34. RPAY short interest (FINRA data) — MarketBeat — 2026-10-09 — https://www.marketbeat.com/stocks/NASDAQ/RPAY/short-interest
  35. Repay attracts $1B takeover offer — Payments Dive — 2026-04-22 — https://www.paymentsdive.com/news/repay-attracts-1b-takeover-offer/818178/
  36. Repay attracts $1B-plus bid — Payments Dive — 2026-06-30 — https://www.paymentsdive.com/news/repay-attracts-1b-plus-bid/824103/
  37. Paymentus Q2 2026 results (8-K Ex. 99.1) — SEC EDGAR — 2026-08-03 — https://www.sec.gov/Archives/edgar/data/0001841156/000119312526330585/pay-ex99_1.htm
  38. Paymentus Holdings Form 10-K FY2025 — SEC EDGAR — 2026-02-24 — https://www.sec.gov/Archives/edgar/data/1841156/000119312526064510/pay-20251231.htm
  39. ACI Worldwide Form 10-Q Q2 2026 — SEC EDGAR — 2026-08-06 — https://www.sec.gov/Archives/edgar/data/935036/000093503626000028/aciw-20260630.htm
  40. Paymentus Holdings Form S-1 — SEC EDGAR — 2021 — https://www.sec.gov/Archives/edgar/data/1841156/000156459021022583/ck7045120534-s1.htm
  41. Repay Form 10-K/A FY2020 and FY2020 results release — SEC EDGAR / Business Wire — 2021-03-01 — https://www.businesswire.com/news/home/20210301005938/en/REPAY-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-Results
  42. Interpretive Rules, Policy Statements, and Advisory Opinions; Withdrawal (CFPB) — Federal Register — 2025-05-12 — https://www.govinfo.gov/content/pkg/FR-2025-05-12/pdf/2025-08286.pdf
  43. Court approves Visa/Mastercard settlement — Payments Dive — 2026-06 — https://www.paymentsdive.com/news/court-approves-visa-mastercard-settlement/822440/
  44. Visa, Mastercard settlement faces merchant pushback in court — Crowdfund Insider — 2026-09 — https://www.crowdfundinsider.com/2026/09/310317-visa-mastercard-settlement-faces-merchant-pushback-in-court/
  45. Fed interchange rule challenge heard by appeals court — America's Credit Unions — 2026-05-15 — https://www.americascreditunions.org/news-media/news/fed-interchange-rule-challenge-heard-appeals-court
  46. Louisiana prohibits debit card surcharges beginning August 1, 2026 — Arnall Golden Gregory — 2026-06 — https://www.agg.com/news-insights/publications/louisiana-prohibits-debit-card-surcharges-beginning-august-1-2026/
  47. USPS Reports Fiscal Year 2025 Results — USPS — 2025-11-14 — https://about.usps.com/newsroom/national-releases/2025/1114-usps-reports-fiscal-year-2025-results.htm
  48. Household Debt and Credit Report Q2 2026 — Federal Reserve Bank of New York — 2026-08-11 — https://www.newyorkfed.org/newsevents/news/research/2026/20260811
  49. Silver Point leads $500 million term loan financing supporting acquisition of KUBRA by REPAY — SFNet — 2026-06-17 — https://www.sfnet.com/home/chapters/canada/news-detail/2026/06/17/silver-point-leads--500-million-term-loan-financing-supporting-acquisition-of-kubra-by-repay
  50. REPAY to Host Investor Day on December 7, 2026 — Business Wire via Finviz — 2026-09-23 — https://finviz.com/news/394948/repay-to-host-investor-day-on-december-7-2026
  51. Repay Q2 2026 earnings call (partial, garbled transcript) — allmind.ai — 2026-08-10 — https://allmind.ai/earnings/event/2947837
Disclaimer. AI-generated research and podcast (Claude by Anthropic, voices by Google Gemini) for educational purposes — not financial advice and not a recommendation to buy or sell. Willem (MR.INVEST) owns this stock. Check the company’s own filings before making any decision.
← All Bulls vs Bears reports